The objective of the present study was to investigate the infectivity and antibody response of four Trichinella species (Trichinella spiralis, Trichinella britovi, Trichinella pseudospiralis and Trichinella murrelli) in experimentally infected pigs. A total of 120 Large White pigs (30 animals per group) were inoculated with 10,000 muscle larvae (ML) of T. spiralis, T. britovi, T. pseudospiralis, and T. murrelli. The pigs were sacrificed at 12-21 days post-infection (dpi) to examine the viability and infectivity of ML. A total of 54 Large White pigs (6 animals per group) were inoculated with 25, 50, 100, 200, 400, 600, 800, 1000 and 10,000 T. spiralis ML. The pigs were sacrificed, and the average numbers of larvae per gram (lpg) from six different muscle tissues were calculated at 120 dpi. The results showed that the larvae first be detectable for T. spiralis, T. britovi, and T. pseudospiralis at 16 dpi, 17 dpi, and 16 dpi, respectively. Viable larvae and average lpg were significantly increased with time from 17 to 21 dpi. The T. spiralis ML burden was dependent of the inoculation dose with an average lpg of 0.003, 0.005, 0.007, 0.17, 0.82, 2.89, 4.90, 28.30 and 226.18, respectively. The IgG antibody response was dose-dependent to generate and increased throughout the experimental period. And the IgG1 isotype was significantly higher than IgG2a, which meant that T. spiralis infection induced the Th2 immune response. The time of detecting IgM antibodies was significantly earlier than IgG antibody detection. These results provide important information in the primary characterization of pigs infected with Trichinella.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vetpar.2020.109111 | DOI Listing |
Nat Commun
December 2024
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Antibody-mediated protection against pathogens is crucial to a healthy life. However, the recent SARS-CoV-2 pandemic has shown that pre-existing comorbid conditions including kidney disease account for compromised humoral immunity to infections. Individuals with kidney disease are not only susceptible to infections but also exhibit poor vaccine-induced antibody response.
View Article and Find Full Text PDFNat Commun
December 2024
Key Laboratory of Immune Response and Immunotherapy, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Scienes, Guangzhou, China.
CD73, an ectoenzyme responsible for adenosine production, is often elevated in immuno-suppressive tumor environments. Inhibition of CD73 activity holds great promise as a therapeutic strategy for CD73-expressing cancers. In this study, we have developed a therapeutic anti-human CD73 antibody cocktail, HB0045.
View Article and Find Full Text PDFNat Commun
December 2024
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Delivering protein drugs to the central nervous system (CNS) is challenging due to the blood-brain and blood-spinal cord barrier. Here we show that neutrophils, which naturally migrate through these barriers to inflamed CNS sites and release neutrophil extracellular traps (NETs), can be leveraged for therapeutic delivery. Tannic acid nanoparticles tethered with anti-Ly6G antibody and interferon-β (aLy6G-IFNβ@TLP) are constructed for targeted neutrophil delivery.
View Article and Find Full Text PDFCureus
November 2024
Hematology and Medical Oncology, Al-Zahraa Medical College, Basrah, IRQ.
Autoimmune hemolytic anemia (AIHA) is a multifactorial disease that causes immune-mediated red blood cell destruction, resulting in anemia and hemolysis symptoms. Despite a significant understanding of its pathogenesis, the precise causes of AIHA remain largely unclear and are thought to be multifactorial. In this paper, we presented a case of sickle cell anemia who developed severe AIHA that failed to maintain response to multiple treatment lines, including steroids, intravenous immunoglobulin, rituximab, and immune suppressive medications.
View Article and Find Full Text PDFIntroduction: Dozens of vaccines have been approved or authorized internationally in response to the ongoing SARS-CoV-2 pandemic, covering a range of modalities and routes of delivery. For example, mucosal delivery of vaccines via the intranasal (i.n.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!